Merck KGaAXSWX:MER +4.03%83 Days Inventory is 208.59 as of Mar. 2026, which is 13% above its 10-year median of 184.34. GuruFocus rates XSWX:MER with a GF Score™ of 83/100 and a GF Value™ of CHF125.76. The stock has 9 warning signs investors should review. Among 916 Drug Manufacturers companies, Merck KGaA ranks worse than 60.92% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Merck KGaA's Average Total Inventories for the
three
months ended in Mar. 2026 was CHF4,305 Mil. Merck KGaA's Cost of Goods Sold for the
three
months ended in Mar. 2026 was CHF1,883 Mil.
Hence, Merck KGaA's Days Inventory for the
three
months ended in Mar. 2026 was 208.59.
The historical rank and industry rank for Merck KGaA's Days Inventory or its related term are showing as below:
XSWX:MER'
s Days Inventory Range Over the Past 10 Years
Min: 177.19 Med: 184.34 Max: 196.7
Current: 191.82
During the past 13 years, Merck KGaA's highest Days Inventory was 196.70. The lowest was 177.19. And the median was 184.34.
XSWX:MER's Days Inventory is ranked worse than 60.92% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs XSWX:MER: 191.82
Merck KGaA's Days Inventory
increased
from Mar. 2025 (190.10) to Mar. 2026 (208.59).
It might indicate that Merck KGaA's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Merck KGaA's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.92.
Merck KGaA (XSWX:MER) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Merck KGaA's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Merck KGaA Days Inventory Related Terms
Merck KGaA Days Inventory Historical Data
* Premium members only.
The historical data trend for Merck KGaA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MER vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck KGaA Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Days Inventory distribution charts can be found below:
* The bar in red indicates where Merck KGaA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA (XSWX:MER) has a Days Inventory of 208.59 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Merck KGaA and its competitors. This is 13% above median its historical median of 184.34. Over the past decade, Merck KGaA's Days Inventory has ranged from 177.19 to 196.70. According to the industry distribution chart, Merck KGaA ranks #558 out of 916 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is Merck KGaA's Days Inventory too high?
Merck KGaA's current Days Inventory of 208.59 is 13% above median its 10-year median of 184.34. Over the past 10 years, this metric has ranged from a low of 177.19 to a high of 196.70. The Drug Manufacturers industry median Days Inventory is 164.43. Merck KGaA's value of 208.59 is 26.9% above this industry median. Based on the distribution chart, Merck KGaA ranks #558 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Merck KGaA has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Merck KGaA ranks #558 out of 916 companies for Days Inventory. This places Merck KGaA in the lower half of its industry. The industry median Days Inventory is 164.43. Merck KGaA's value of 208.59 is 26.9% above this benchmark. Historically, Merck KGaA's own Days Inventory has ranged from 177.19 to 196.70 over the past decade. While the company's 10-year median is 184.34 vs. the industry median of 164.43, Merck KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merck KGaA's current Days Inventory of 208.59 is 26.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Merck KGaA and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merck KGaA's current Days Inventory is 208.59, which is 13% above median its own 10-year median of 184.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current Days Inventory of 208.59. The stock's GF Value™ is CHF125.76, compared to a current price of CHF130.30 — trading 3.6% above its estimated fair value. The current Days Inventory is 208.59, which is 13% above median its 10-year median of 184.34 and 26.9% above the Drug Manufacturers industry median of 164.43. Merck KGaA's overall GF Score™ is 83/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Days Inventory is 208.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (XSWX:MER) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be overvalued.
The current stock price of CHF130.30 is trading 3.6% above its estimated GF Value™ of CHF125.76.
Key valuation signals for XSWX:MER:
Days Inventory: 208.59 (13% above median its 10-year median of 184.34)
GF Value™: CHF125.76 vs. price of CHF130.30 (3.6% above fair value)
Industry Position: 26.9% above the Drug Manufacturers median (#558 of 916)
No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
83GF Score
Get the complete analysis for XSWX:MER
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MER has been successfully added to your 
